Annapolis, MD, United States
Valgene Incorporated dba Cape Drugs recalls
1 recall recorded since 2018, most recently on 3 December 2021. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)0
Terminated Class II Drugs
- Recall started
- 3 December 2021
- Terminated
- 4 January 2022
- Reason
- Lack of Processing Controls
- Distribution
- Maryland Only
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-0284-2022, D-0283-2022
- B-Complex, injection, 1 mL vials, Rx only, Cape Drugs 1384 Cape St. Claire Road Annapolis, MD 21409
- Methylcobalamin 12mg/ml injection, 1 mL vials, Rx only, Cape Drugs 1384 Cape St. Claire Road Annapolis, MD 21409
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.